We have detected that you are using Internet Explorer to visit this website. Internet Explorer is now being phased out by Microsoft. As a result, NHS Digital no longer supports any version of Internet Explorer for our web-based products, as it involves considerable extra effort and expense, which cannot be justified from public funds. Some features on this site will not work. You should use a modern browser such as Edge, Chrome, Firefox, or Safari. If you have difficulty installing or accessing a different browser, contact your IT support team.
Prescribing Costs in Hospitals and the Community, England 2014/15
Official statistics- Publication Date:
- 12 Nov 2015
- Geographic Coverage:
- England
- Geographical Granularity:
- Regions, Country, Strategic Health Authorities
- Date Range:
- 01 Apr 2014 to 31 Mar 2015
Summary
This report compares expenditure between primary and secondary care in total and for medicines positively appraised by NICE.
Highlights
The overall NHS expenditure on medicines in 2014-15 was £15.5 billion, an increase of 7.8 per cent from £14.4 billion in 2013-14 and an increase of 19.4 per cent from £13.0 billion in 2010-11.
In 2014-15 hospital use accounted for 42.9 per cent of the total cost, up from 40.1 per cent in 2013-14 and up from 32.1 per cent in 2010/11.
The cost of medicines rose by 7.8 per cent overall but by 15.4 per cent in hospitals, from 2013-14 to 2014-15. The cost of medicines in hospitals has risen by 59.8 per cent since 2010-11.
Of the drugs positively appraised by NICE, the greatest overall cost in 2014-15 was for Adalimumab (£371.2m), which also incurred the greatest cost (over £348.2 million) in hospitals.